These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1948183)

  • 1. [Continuous ambulatory peritoneal dialysis. Indications].
    Faller B
    Soins; 1991 Jun; (549):20, 22. PubMed ID: 1948183
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous ambulatory peritoneal dialysis (CAPD): eight years after its introduction.
    Sombolos K; Oreopoulos DG
    Life Support Syst; 1985; 3 Suppl 1():96-106. PubMed ID: 3916636
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis (CAPD).
    Mulgaonkar S; Lyman N; Viscuso R; Jacobs MG
    J Med Soc N J; 1983 Jun; 80(6):427-30. PubMed ID: 6577192
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis and transplantation for diabetic nephropathy: the Dublin experience 1977-1985.
    Blake P; Donohoe J; Carmody M; Walker J; Keogh B; Drury I
    Ir Med J; 1986 Dec; 79(12):354-7. PubMed ID: 3542891
    [No Abstract]   [Full Text] [Related]  

  • 5. The management of end-stage renal disease (ESRD) in diabetes mellitus (DM) in Canada in 1981.
    Posen G; Lam E; Rappoport A
    Trans Am Soc Artif Intern Organs; 1983; 29():116-9. PubMed ID: 6369724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dialysis treatment in diabetic nephropathy--a review].
    Tranaeus A
    Lakartidningen; 1986 Sep; 83(38):3122, 3124-5, 3127. PubMed ID: 3534497
    [No Abstract]   [Full Text] [Related]  

  • 7. Is continuous ambulatory peritoneal dialysis the best dialysis choice for insulin dependent diabetics?
    Rottembourg J; de Groc F; Poignet JL; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():215-20. PubMed ID: 6348737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment by continuous ambulatory peritoneal dialysis for chronic renal insufficiency in the diabetic].
    Rottembourg J; Issad B; Allouache M; Diab R; Hamani A; Jacobs C
    Nephrologie; 1995; 16(1):111-21. PubMed ID: 7700411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal replacement therapy utilizing hemodialysis and peritoneal dialysis.
    Paganini EP; Vidt DG
    Urol Clin North Am; 1983 May; 10(2):347-67. PubMed ID: 6344391
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors associated with peritonitis among patients on continuous ambulatory peritoneal dialysis (CAPD).
    Steinberg SM; Cutler SJ; Novak JW; Nolph KD
    Trans Am Soc Artif Intern Organs; 1985; 31():565-7. PubMed ID: 3837508
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term continuous ambulatory peritoneal dialysis.
    Flynn CT
    Proc Eur Dial Transplant Assoc; 1983; 20():700-4. PubMed ID: 6657690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of the diabetic with terminal renal failure].
    Ritz E; Bommer J; Andrassy K
    MMW Munch Med Wochenschr; 1983 Jun; 125(24):516-20. PubMed ID: 6410221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetic nephropathy].
    Morell B; Blumberg A; Descoeudres C; Wauters JP
    Schweiz Rundsch Med Prax; 1986 May; 75(21):641-4. PubMed ID: 3523678
    [No Abstract]   [Full Text] [Related]  

  • 15. Is peritoneal dialysis the preferred modality in the diabetic patient?
    Kraus MA; Hamburger RJ
    Adv Perit Dial; 1996; 12():89-92. PubMed ID: 8865879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous peritoneal dialysis of diabetic patients with end-stage renal insufficiency].
    Frandsen NE; Jacobsen IA; Pedersen FB
    Ugeskr Laeger; 1986 Feb; 148(9):513-6. PubMed ID: 3961997
    [No Abstract]   [Full Text] [Related]  

  • 17. Three and a half years experience with CAPD using the Beta Cap technique.
    Mavichak V; Moriarty MV; Cameron EC; Reeve CE; Ballon HS; Lauener RW; Price JD
    Trans Am Soc Artif Intern Organs; 1982; 28():253-8. PubMed ID: 7164246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selected problems in the treatment of diabetic nephropathy].
    Starzyk J; Kowalski D
    Wiad Lek; 1985 Mar; 38(6):427-31. PubMed ID: 3892921
    [No Abstract]   [Full Text] [Related]  

  • 19. Xylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F; Onesti G
    Trans Am Soc Artif Intern Organs; 1982; 28():280-6. PubMed ID: 6761936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.